Please assess the completion status of the following clinical trial:

Trial Title: A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of RA based on 2010 ACR/EULAR for RA for at least a 4 month duration.~* Moderately to severely active RA based on local standard of care.~Exclusion Criteria:~-Evidence of untreated or inadequately treated latent or active TB.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Arm 1 (Type: EXPERIMENTAL): Subcutaneous (SC) injection given every other week
- Treatment Arm 2 (Type: ACTIVE_COMPARATOR): SC injection given every other week

Based on this trial design, predict the completion outcome and termination type (if applicable).